Home Other Building Blocks 1575-72-0
1575-72-0,MFCD00869309
Catalog No.:AA001PFD

1575-72-0 | 4-Pentenoic acid, 2-propyl-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10mg
≥98%
in stock  
$46.00   $32.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA001PFD
Chemical Name:
4-Pentenoic acid, 2-propyl-
CAS Number:
1575-72-0
Molecular Formula:
C8H14O2
Molecular Weight:
142.1956
MDL Number:
MFCD00869309
SMILES:
CCCC(C(=O)O)CC=C
Properties
Computed Properties
 
Complexity:
118  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
1  
XLogP3:
2.3  

Literature

Title: Simultaneous determination of valproic acid and 2-propyl-4-pentenoic acid for the prediction of clinical adverse effects in Chinese patients with epilepsy.

Journal: Seizure 20120301

Title: Role of oxidative metabolism in the effect of valproic acid on markers of cell viability, necrosis, and oxidative stress in sandwich-cultured rat hepatocytes.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20101201

Title: Dose-dependent pharmacokinetics of toxic metabolites is not related to increased toxicity following high-dose valproic acid in rats.

Journal: Journal of applied toxicology : JAT 20101101

Title: Formulations of valproate alter valproate metabolism: a single oral dose kinetic study.

Journal: Therapeutic drug monitoring 20091001

Title: The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.

Journal: Archives of pharmacal research 20090701

Title: Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes.

Journal: FEBS letters 20081015

Title: Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

Title: Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20061201

Title: Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives.

Journal: Biochemical pharmacology 20050515

Title: Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Journal: Critical care (London, England) 20050101

Title: Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds.

Journal: Bioorganic & medicinal chemistry letters 20041115

Title: Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids.

Journal: Chemico-biological interactions 20010928

Title: Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.

Journal: Chemical research in toxicology 19950101

Title: Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis.

Journal: Neurology 19920401

Title: Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity.

Journal: Epilepsia 19920101

Title: On the development of alternative antiepileptic drugs. Lack of enantioselectivity of the anticonvulsant activity, in contrast to teratogenicity, of 2-n-propyl-4-pentenoic acid and 2-n-propyl-4-pentynoic acid, analogues of the anticonvulsant drug valproic acid.

Journal: Die Naturwissenschaften 19910601

Title: Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid.

Journal: Toxicology letters 19891001

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1575-72-0 Molecular Formula|1575-72-0 MDL|1575-72-0 SMILES|1575-72-0 4-Pentenoic acid, 2-propyl-